Exercise slashes risk of death in patients with colon cancer
Colon cancer develops in the part of the large intestine known as the colon, part of the large bowel, which also comprises the rectum and anus.
It can sometimes be referred to as bowel cancer or colorectal cancer.
Cancer Research UK estimates about 31,800 people every year in the UK are diagnosed with the disease, with around 9,500 deaths.
The CO21 Challenge trial, led by researchers in Northern Ireland and Canada, involved 889 people with colon cancer from six countries, including the UK.
All patients had had surgery and chemotherapy for their cancer and were deemed well enough to exercise, but were not meeting recommended physical activity levels.
Around half were given a three-year tailored exercise programme, which included the likes of brisk walking, circuit classes, cycling, or swimming.
The plan included in-person coaching sessions for the first six months, as well as regular meetings with a physical activity consultant.
The other group were offered materials that promoted exercise and nutrition.
The study found that after five years, the risk of dying, relapse or developing a new cancer was 28% lower in the group with a tailored exercise plan.
After eight years, patients in the physical activity group had a 37% lower risk of death.
Professor Vicky Coyle, UK lead researcher for the trial and clinical professor at Queen's University Belfast, said: 'During the trial, we supported people to reach their weekly exercise target in a way that worked for them.
'This could be a brisk walk for around 40 minutes every day, but some patients were also doing circuit classes, cycling, swimming, and many other activities.
'Our study gives clear, encouraging evidence that physical activity can reduce the risk of cancer returning for some people with colon cancer.
'We now need to work with policymakers and healthcare providers to embed exercise into treatment plans where appropriate.'
Dr Joe Henson, associate professor in lifestyle medicine at the University of Leicester, said: 'Leading the exercise sessions in Leicester, I saw first-hand that this reduced fatigue, lifted people's mood, and boosted their physical strength.
'We know that physical activity regulates several key biological processes that could explain these results, and further research will help us uncover why exercise is having such a positive impact.'
The findings, published in the New England Journal of Medicine and presented at the American Society of Clinical Oncology (ASCO), could 'transform clinical practice', according to experts.
Caroline Geraghty, senior specialist information nurse at Cancer Research UK, which part-funded the CO21 Challenge through Stand Up To Cancer, said: 'Being active has many benefits, and this study shows that exercise doesn't only improve well-being – it can also boost people's chances of surviving colon cancer.
'Everyone recovering from cancer should have access to tailored support to help them live longer, better lives.
'This trial has the potential to transform clinical practice, but only if health services have the necessary funding and staff to make it a reality for patients.
'It's important to remember that every cancer journey is different – starting new activities after treatment can feel overwhelming, and it may not be the right option for everyone. Take things at your own pace and speak to your doctor to discuss what is safe for you.'
Professor Peter Johnson, NHS national clinical director for cancer, said: 'These exciting findings add to the growing evidence of the benefits of physical activity for people affected by cancer, not just in helping them be fitter for treatment and boosting their immediate recovery, but reducing the risk of the disease coming back.
'This is why we've asked cancer alliances across the country to look at ways to encourage and support patients to do physical activity and ensure every healthcare professional they see can help them be in the best possible place – both physically and mentally – before, during and after treatment.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
a day ago
- BBC News
Covid-19 Inquiry: Disability campaigner lays out care sector issues
A Belfast woman with cerebral palsy has told the Covid-19 Inquiry that living alone in sheltered accommodation during the pandemic without direct contact with family was "really frightening".Giving evidence on behalf of Disability Action, Joanne Sansome said staff shortages in the care sector meant many of her friends were stuck in bed for days without direct Sansome, who campaigns on behalf of those with disabilities, said she stopped counting the days when she reached described how no one really explained to those with disabilities what was happening and how their lives would be impacted by the virus. The inquiry heard how Fridays soon became known as fabulous Fridays when her dad left treats for her and all those living within her sheltered accommodation including the she said the care sector was not treated the same as other areas of health care, which became visible with the lack of personal protective equipment (PPE).At one point, Ms Sansome reached out to contacts at Queen's University Belfast to access PPE when staff in her home did not have enough."It was crazy at that time. I kept thinking of my friends who lived by themselves in their own homes and how they were stuck in bed for days because of the shortages," Ms Sansome told the Inquiry."There were days that you weren't guaranteed a shower or full care. Staff did their best but going forward things like that need to be planned for."Ms Sansome, who flew to London to attend the inquiry in person, described how her laptop became her visual window to the world and how it allowed her to communicate with family and friends. During the summer of 2020, she attended a daily virtual summer camp for disabled people located in America which she said she had always wanted to go to and, albeit virtually, the pandemic let her do said ensuring those with disabilities could communicate was essential and providing people with tools such as laptops should become part of any future preparation for another asked by counsel to the inquiry how disabled people were treated differently Ms Sansome said when care staff tested positive it affected the entire sheltered dwelling with everyone told to isolate, even if they tested that happened at Christmas and Ms Sansome was told by the Public Health Agency that she would have to stay alone in her apartment she rang an MLA who a result, most of her neighbours were allowed to go home to their families to eat Christmas Day 2022 (the end of lockdown rules on 19 July 2022) according to Ms Sansome was not freedom day for all as restrictions were not lifted for those who were clinically vulnerable, which Ms Sansome said was Sansome said she felt the announcement was made as an election was approaching."The cynical side of me felt it was only announced by politicians to look good," she told the inquiry. "They always said they were following the science, but I was never too sure what was science and what was political spin."
Daily Mirror
2 days ago
- Daily Mirror
Breakthrough in breast cancer research could stop the disease from spreading
The discovery offers new hope in the fight against breast cancer, as it could detect and stop the spread of the disease before it becomes incurable Scientists have achieved a significant breakthrough in the battle against breast cancer by dismantling the very components that enable the deadly disease to metastasise. Researchers have discovered that cancer alters the metabolism of certain immune cells, causing them to release a metabolite known as uracil, which aids in constructing a 'scaffold' within distant organs, facilitating the growth of secondary tumours. By inhibiting the enzyme uridine phosphorylase-1 (UPP1), responsible for producing uracil, scientists were able to prevent this 'scaffold' from forming in mice and rejuvenated the immune system's capacity to eliminate secondary cancer cells, thereby thwarting metastasis. This groundbreaking work was carried out in the laboratories of Professor Jim Norman and Professor Karen Blyth at the Cancer Research UK Scotland Institute and the University of Glasgow. This discovery paves the way for potentially potent new methods to combat cancer – identifying uracil in the bloodstream could signal early indications of cancer metastasis, while impeding UPP1 with medication could halt its progression before it even begins. The study's lead author, Dr Cassie Clarke, from the Cancer Research UK Scotland Institute and University of Glasgow, said: "This study represents a major shift in how we think about preventing the spread of breast cancer. By targeting these metabolic changes as early as possible we could stop the cancer progressing and save lives." Published in Embo Reports, the research indicates that crucial metabolic alterations take place prior to the dissemination of cancer, presenting an essential opportunity for intervention. Identifying these alterations at an early stage could enable treatments to prevent cancer cells from migrating throughout the body and establishing tumours in different locations. Dr Catherine Elliott, Cancer Research UK's director of research, explained: "Discoveries in cancer research have made huge strides in making breast cancer a far more treatable disease than ever before. However, metastasis - when cancer spreads - is a major factor in breast cancer becoming harder to treat especially if the cancer returns months or even many years later. "This discovery gives us new hope for detecting and stopping metastasis early and ensuring people have many more years with their families and loved ones." With approximately 56,800 people receiving a breast cancer diagnosis in the United Kingdom annually and roughly 11,300 people dying from it each year, discovering innovative approaches to combat it remains crucial. Due to research breakthroughs, breast cancer has evolved into a significantly more manageable illness, yet when it metastasises to different parts of the body, effective control becomes increasingly challenging. Comprehending the mechanisms behind breast cancer's spread is essential to preventing the disease from becoming uncontrollable with existing treatments. The research team is now delving deeper into precisely how UPP1 alters immune cell behaviour, examining the function of immune cell metabolism in early breast cancer development, and evaluating the potential of medications that inhibit immune cell metabolism to prevent cancer onset. Simon Vincent, the chief scientific officer at Breast Cancer Now, said: "This is an exciting piece of joint research that expands our understanding of how secondary breast cancer develops. "The researchers discovered that high levels of a protein called UPP1 may make some cancers, including breast cancer, more likely to spread to other parts of the body, where the disease becomes incurable. "In mice, targeting the UPP1 protein before secondary breast cancer developed led to fewer secondary breast tumours and a boosted immune response in the lungs. "Now we need more research to see if this new insight can be turned into new drugs that stop secondary breast cancer, and potentially other secondary cancers, in their tracks. With around 61,000 people living with secondary breast cancer in the UK, research like this is vital."
Daily Record
3 days ago
- Daily Record
Scots scientists make breast cancer discovery that could stop disease spreading
The discovery could offer patients a vital new window for cancer intervention. A team of Scots scientists have made a groundbreaking new discovery which could help stop the spread of breast cancer - one of the leading causes of death from the disease. Under the research, conducted by experts at the Cancer Research UK Scotland Institute and the University of Glasgow, patients could be offered a vital new window for intervention. The study focused on how breast cancer changes the immune system so it can't tackle cancer cells as they begin to spread. The researchers found that cancer changes the metabolism (the way cells make and use energy) of specific immune cells resulting in them releasing a prominent metabolite called uracil. Uracil is a molecule key to essential processes in the body which was found to help distant organs build a 'scaffold' to grow secondary tumours elsewhere in the body. By blocking an enzyme called uridine phosphorylase-1 (UPP1), which produces uracil, the scientists were able to stop this scaffold forming in mice and restore the ability of the immune system to kill secondary cancer cells to prevent metastasis. It opens the door to new potentially powerful new tools to tackle cancer - detecting uracil in the blood could help spot early signs of cancer spread then blocking UPP1 with drugs could stop the spread before it starts. The study was conducted in the labs of Professor Jim Norman and Professor Karen Blyth at the Cancer Research UK Scotland Institute and the University of Glasgow. Study lead Dr Cassie Clarke, of the Cancer Research UK Scotland Institute and University of Glasgow, said: "This study represents a major shift in how we think about preventing the spread of breast cancer. By targeting these metabolic changes as early as possible we could stop the cancer progressing and save lives.' Every year, around 56,800 people are diagnosed with breast cancer in United Kingdom. Around 11,300 people sadly lose their lives to the disease. Thanks to research, breast cancer has become a far more treatable disease, but once it spreads to other areas within the body it becomes harder to control effectively. Understanding how and why breast cancer spreads is key to preventing the disease becoming unmanageable with current therapies. Cancer Research UK's Director of Research, Dr Catherine Elliott, said: ' Discoveries in cancer research have made huge strides in making breast cancer a far more treatable disease than ever before. 'However, metastasis - when cancer spreads - is a major factor in breast cancer becoming harder to treat especially if the cancer returns months or even many years later. 'This discovery gives us new hope for detecting and stopping metastasis early and ensuring people have many more years with their families and loved ones.' Simon Vincent, chief scientific officer at Breast Cancer Now, said: 'This is an exciting piece of joint research that expands our understanding of how secondary breast cancer develops. 'The researchers discovered that high levels of a protein called UPP1 may make some cancers, including breast cancer, more likely to spread to other parts of the body, where the disease becomes incurable. 'In mice, targeting the UPP1 protein before secondary breast cancer developed led to fewer secondary breast tumours and a boosted immune response in the lungs. 'Now we need more research to see if this new insight can be turned into new drugs that stop secondary breast cancer, and potentially other secondary cancers, in their tracks. With around 61,000 people living with secondary breast cancer in the UK, research like this is vital."
